Lack of efficacy of tocilizumab in severe axial refractory spondyloarthritis: a report of 5 patients

Clin Exp Rheumatol. 2012 Sep-Oct;30(5):805. Epub 2012 Oct 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Axis, Cervical Vertebra / drug effects*
  • Axis, Cervical Vertebra / immunology
  • Drug Resistance
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Middle Aged
  • Prospective Studies
  • Severity of Illness Index
  • Spondylarthritis / diagnosis
  • Spondylarthritis / drug therapy*
  • Spondylarthritis / immunology
  • Time Factors
  • Treatment Failure

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • tocilizumab